Tom Watts

Tom Watts is a partner at Girard Sharp who concentrates his practice on antitrust, investment fraud and consumer protection litigation.

Tom’s current matters include representing a certified class of investors in the Maxar Securities Litigation, which resulted in a $36.5 million settlement, one of the largest securities judgments ever obtained in California state court. He is also part of the Girard Sharp co-lead counsel team in the Xyrem Antitrust Litigation, a high-stakes generic suppression case. Tom also contributes to the firm’s work as a member of Executive Committees in the Generic Pharmaceuticals Antitrust Litigation in Philadelphia federal court and the In re Philips Recalled CPAP, Bi-Level Pap, and Mechanical Ventilator Products Litigation in Pittsburgh.

Tom previously served on the lead counsel team in the Restasis Antitrust Litigation, helping to achieve a $30 million settlement with pharma giant Allergan for end-purchasers of Restasis, a dry-eye medication. Tom also participated in Girard Sharp’s representation of the California State Teachers’ Retirement System in a non-class securities case against Allergan, securing a confidential settlement for CalSTRS. Tom’s work in consumer cases includes securing refunds and additional cash payments for COVID 19-related cancellations for British Airways passengers.

Tom is a magna cum laude graduate of Harvard Law School, concurrently receiving a Master of Public Policy from the Harvard Kennedy School. Tom received his B.A. from the University of California, Berkeley, with High Distinction in General Scholarship.

Before joining the firm, Tom clerked for the Honorable Jane Roth of the Third Circuit Court of Appeals and the Honorable Robert McDonald of the Maryland Court of Appeals.

Tom was named to the Northern California Super Lawyers “Rising Stars” list in 2021 and 2022.